A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL

Area of Science:

• Biochemistry
• Cardiovascular Research
• Biomedical Assays

Background:

• Current cell-based assays for assessing high-density lipoprotein (HDL) functionality are limited.
• There is a need for robust, reproducible, and high-throughput methods to evaluate HDL quality.

Purpose of the Study:

• To develop and validate a novel, cell-free biochemical assay for measuring HDL lipid peroxidation (HDLox).
• To assess the correlation of the new HDLox assay with existing methods and clinical markers of cardiovascular disease.

Main Methods:

• Development of a fluorometric assay utilizing Amplex Red to quantify HDL lipid peroxidation.
• Validation against established cell-based and cell-free HDL assays.
• Application of the assay in animal models of atherosclerosis and in Human Immunodeficiency Virus (HIV) patients.
• Utilized immunoaffinity capture for high-throughput HDL isolation.

Main Results:

• The novel HDLox assay demonstrated significant correlations with previously validated HDL assays (r = 0.47 and r = 0.46).
• HDLox levels effectively distinguished dysfunctional HDL in atherosclerosis models and HIV patients.
• HDLox showed significant correlations with cardiovascular disease indicators like carotid intima media thickness and subendocardial viability ratio.

Conclusions:

• A robust, fluorometric, cell-free assay for HDL lipid peroxidation (HDLox) has been successfully developed.
• This assay provides a reproducible and rapid method for assessing HDL function and quality.
• The assay is suitable for high-throughput implementation and shows clinical relevance in cardiovascular disease assessment.